MELISSA VORPAHL: Open Payments
NPI 1619477833 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 54 payments from 34 companies in 2025. Trend: 2023 $1,224 · 2024 $1,294 · 2025 $1,184
Food & beverage: $1,109Education: $75
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $192 |
| Gilead Sciences, Inc. | 4 | $129 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $55 |
| Janssen Biotech, Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $45 |
| BeOne Medicines USA, Inc. | 2 | $43 |
| Celgene Corporation | 1 | $36 |
| TerSera Therapeutics LLC | 1 | $26 |
Products named: Trodelvy, Xtandi, Enhertu, IMBRUVICA, Padcev, BRUKINSA, REBLOZYL, TAGRISSO.
Industry payments across SC — which companies pay providers there.
